FDA Panel Nixes Humira for Spinal Arthritis

FDA Panel Nixes Humira for Spinal Arthritis
SILVER SPRING, Md. — An independent panel of FDA advisers overwhelmingly rejected AbbVie's bid to gain approval of Humira (adalimumab) for treatment of treat active nonradiographic axial spondyloarthritis in adults with signs of inflammation by … Read more on MedPage Today

Womens Powder Puff game supports 18-month-old's battle against eye cancer
In her search, she discovered Dr. David Abramson at the Memorial Sloan-Kettering Cancer Center in New York City. … Phoebe has gone through four rounds of chemotherapy, and depending on the results of the last treatment, may be done for now. Lee said … Read more on Montgomery Newspapers